BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Bristol-Myers Squibb Release: First Presentation Of Efficacy Data From Checkmate -204 Evaluating The Combination Of Opdivo (Nivolumab) And Yervoy (Ipilimumab)Demonstrates Anti-Tumor Activity In Advanced Melanoma Patients With Brain Metastases

  June 5, 2017

   · 

  11 min read
• Drug Development

  NewLink Genetics Release: Results From Clinical Trial Of Indoximod Plus Chemotherapy For Patients With Metastatic Breast Cancer

  June 5, 2017

   · 

  3 min read
• BioMidwest

  Myriad Genetics Announces 17 Additional Health Insurance Plans Covering EndoPredict

  June 5, 2017

   · 

  6 min read
• BioMidwest

  NantWorks Release: NantOmics To Present Clinical Trial Data On The Characterization Of Molecular Profiles Of Metastatic Triple Negative Breast Cancer With GPS Cancer™ At ASCO 2017 Annual Meeting

  June 5, 2017

   · 

  5 min read
• BioMidwest

  Myriad Genetics’s BRACAnalysis CDx Test Identified Patients With Metastatic Breast Cancer Who Benefited From Treatment With Olaparib In Phase III OlympiAD Study

  June 5, 2017

   · 

  9 min read
• Drug Development

  Eli Lilly Builds Upon Body Of Data For Abemaciclib With Phase III MONARCH 2 Data Demonstrating Superior Progression-Free Survival In Advanced Breast Cancer

  June 5, 2017

   · 

  9 min read
• Drug Development

  Further Study Of Combination Of Eisai Inc.'s Lenvatinib And Merck & Co.'s Pembrolizumab In Previously Treated Patients With Metastatic Endometrial Cancer Supported By Interim Analysis Of Ongoing Phase Ib/II Trial

  June 5, 2017

   · 

  16 min read
• Drug Development

  ARMO BioSciences Announces Promising Response Rates And Survival Data In Patients With Advanced NSCLC And RCC From Phase I/Ib Trial For Immunotherapy AM0010 With Checkpoint Inhibitors

  June 5, 2017

   · 

  7 min read
• Drug Development

  Amgen Presents New Data From Phase III XGEVA (Denosumab) Study In Patients With Multiple Myeloma At ASCO 2017

  June 5, 2017

   · 

  18 min read
• Drug Development

  CARsgen Therapeutics Presents Phase I Results Of CAR-GPC3 T HCC Trial At ASCO 2017 Annual Meeting

  June 5, 2017

   · 

  2 min read